NCT02688517Recruiting
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Targeted Genomic Analysis of Human Cancers
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1100 (estimated)
- First submitted
- 17 Feb 2016
- Start date
- Feb 2013
- Primary completion date
- May 2030
- Lead sponsor
- Rutgers, The State University of New Jersey
- Diseases
- Childhood cancers
- NCT number
- NCT02688517
What you commit to
- Study type: Observational
- Planned participants: 1100
- From Feb 2013 to the primary completion date, May 2030
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Karnofsky/Lansky performance score \< 30
- Life expectancy \< 3 months
Who the study is looking for
- Karnofsky/Lansky performance score \>= 30
- A signed written informed consent
- Evaluation in surgical/medical/radiation oncology/radiology clinic, with a history of biopsy-confirmed diagnosis of cancer of rare histology and/or poor prognosis with standard therapy; priority will be given to rare cancers with poor prognosis and lack of effective standard therapy; study principal investigator (PI) or designee will review and approve each case before enrollment
- Paraffin blocks of the patient's tumor tissue are available and accessible for analysis
Age in the registry: 1 year to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ocean Medical Center Coordinator of this site? Confirm its status | Brick | United States | Completed |
| Bayshore Community Hospital Coordinator of this site? Confirm its status | Holmdel | United States | Completed |
| RWJBarnabas Health - Jersey City Medical Center, Jersey City Coordinator of this site? Confirm its status | Jersey City | United States | Recruiting |
| University of Wisconsin Hospital and Clinics Coordinator of this site? Confirm its status | Madison | United States | Withdrawn |
| Southern Ocean County Medical Center Coordinator of this site? Confirm its status | Manahawkin | United States | Completed |
| Morristown Medical Center Coordinator of this site? Confirm its status | Morristown | United States | Completed |
| Jersey Shore Medical Center Coordinator of this site? Confirm its status | Neptune City | United States | Completed |
| Rutgers Cancer Institute of New Jersey Coordinator of this site? Confirm its status | New Brunswick | United States | Recruiting |
| Riverview Medical Center Coordinator of this site? Confirm its status | Red Bank | United States | Active, not recruiting |
| Riverview Medical Center/Booker Cancer Center Coordinator of this site? Confirm its status | Red Bank | United States | Completed |
| Overlook Hospital Coordinator of this site? Confirm its status | Summit | United States | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.